Shah Capital pushes for Novavax sale, warns of proxy fight
1. Shah Capital demands strategic changes at Novavax, threatens a proxy fight. 2. Potential sale discussions could significantly affect NVAX's future direction.
1. Shah Capital demands strategic changes at Novavax, threatens a proxy fight. 2. Potential sale discussions could significantly affect NVAX's future direction.
Activist pressure can lead to positive changes in governance and strategy, exemplified by companies like Yahoo and eBay, which improved after shareholder interventions.
The involvement of Shah Capital indicates a significant level of shareholder engagement that can lead to strategic changes influencing NVAX's stock performance.
With a four-month timeline for action, the implications will likely influence NVAX's stock price soon, similar to past instances where activism led to immediate volatility.